Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Loading ETF research
Fetching the latest fund profile, holdings, and market data.

Chicago Board Options ExchangeEquity
Previous close
$41.8884
−$0.4218 · -1.00%
Sep 4, 3:53 PM ET
Regular session · ET · Market data may be delayed.
This fund aims to generate substantial capital growth by strategically investing in a diverse array of equity securities. Its portfolio includes companies based within the United States as well as those operating in international markets, encompassing both established and emerging economies. The core investment thesis of the fund centers on companies engaged in genomic advancements. Specifically, it seeks out firms that the investment manager believes are fundamentally dedicated to, or are poised to significantly benefit from, efforts to prolong and enhance the overall quality of life for both humans and animals. This is accomplished by integrating cutting-edge technological and scientific innovations, improvements, and breakthroughs in the field of genomics directly into their business models and operations.
Fund assets
31.84M USD
Expense ratio
0.50%
NAV
$42.45
Average volume
1.99K
Volume
1.58K
Day range
$41.76 – $41.89
52-week range
$29.80 – $43.509
Previous close
$42.3102
Price change
1 day
-1.00%
1 month
+5.19%
3 months
+20.37%
Year to date
+15.36%
1 year
+37.29%
3 years
+38.80%
5 years
-28.06%
Price changes exclude distributions, fees, taxes, and investor-specific cash flows.
Portfolio
Holdings data updated Sep 6, 2026.
Portfolio composition
Fund income
Dec 30, 2025
Dec 30, 2025
Jan 8, 2026
$0.1433
Irregular
Dec 30, 2021
Dec 31, 2021
Jan 7, 2022
$0.0039
Monthly
Dec 13, 2021
Dec 14, 2021
Dec 21, 2021
$0.1142
Annual
Dec 14, 2020
Dec 15, 2020
Dec 23, 2020
$0.0518
Annual
Latest coverage
No ETF news is currently available.
More funds
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.